Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
HIKAL Stock Analysis
Views
Red Flags
Positive
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Negative
Expensive and at a premium to industry median P/E
Weak price momentum
Analysts have been downgrading forward EPS estimates
Low and declining ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
HIKAL Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
HIKAL Bulk, Block & Insider Trades
HIKAL Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Bonus(1 new shares for 2 existing shares) Ex-date: 22nd Jun 2018 Announced on: 9th May 2018
Bonus(1 new shares for 2 existing shares)The Board of Directors of the company has announced bonus shares in the ratio of 1 new share for every two shares held. Ex-date: 29th Sep 2003 Announced on: 15th Jul 2003
Bonus(1 new shares for 1 existing shares) Ex-date: 23rd Aug 2000 Announced on: 23rd Aug 2000
Stock split(1 : 5)Nominal value change from INR 10 to INR 2. Ex-date: 27th Feb 2015 Announced on: 17th Dec 2014
Company Profile
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Ban... Read More
Key personnel
Mr. Jai HiremathD
Executive Chairman of the Board
Mr. Sameer HiremathD
Chief Executive Officer, Managing Director, Executive Director
Mr. Kuldeep Jain
Chief Financial Officer
Mr. Ratish Jha
President - Human Resources
Mr. Vimal Kulshrestha
President - Crop Protection
Mr. Manoj Mehrotra
President - Pharmaceuticals
Mr. Anish Dilip Swadi
Senior President - Animal Health and Business Transformation
Mr. Rajasekhar Reddy
Compliance Officer, Company Secretary
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Hikal Ltd.?
The current share price of Hikal Ltd. is ₹ 215.48 as of 09 Jan 2026.
What is the PE ratio of Hikal Ltd.?
The Price-to-Earnings (PE) ratio of Hikal Ltd. is 263.06 as of the latest financial data.
What is the ROE and ROCE of Hikal Ltd.?
Hikal Ltd. has a Return on Equity (ROE) of 0.84% and a Return on Capital Employed (ROCE) of 3.96% as per the latest financial reports.
What is the market cap of Hikal Ltd.?
The market capitalization of Hikal Ltd. stands at ₹ 2,656.89 Cr.
What is the dividend yield of Hikal Ltd.?
The dividend yield of Hikal Ltd. is 0.65% based on the current market price.
What is the RSI of Hikal Ltd.?
The Relative Strength Index (RSI) of Hikal Ltd. is 31.02.
What is the FII and DII holding in Hikal Ltd.?
Foreign Institutional Investors (FII) hold 4.23% and Domestic Institutional Investors (DII) hold 4.09% of Hikal Ltd. shares.
What sector does Hikal Ltd. belong to?
Hikal Ltd. operates in the Healthcare sector.
What is the beta of Hikal Ltd. stock?
The beta of Hikal Ltd. stock is 0.87, indicating its volatility relative to the broader market.
